- Half Year 2024 Healius Ltd Earnings Call TranscriptFeb 27, 2024A$1.27 (-8.66%)Earnings
- Healius Ltd Annual Shareholders Meeting TranscriptNov 28, 2023
- Healius Ltd Conference Call TranscriptNov 22, 2023
- Full Year 2023 Healius Ltd Earnings Call TranscriptAug 30, 2023A$2.7 (+7.75%)Earnings
- Australian Clinical Labs Ltd To Merge with Healius Ltd Call TranscriptMar 19, 2023
- Half Year 2023 Healius Ltd Earnings Call TranscriptFeb 27, 2023A$2.6 (-4.10%)Earnings
- Healius Ltd Annual Shareholders Meeting TranscriptOct 20, 2022
- Full Year 2022 Healius Ltd Earnings Call TranscriptAug 30, 2022A$3.54 (+3.51%)Earnings
- Half Year 2022 Healius Ltd Earnings Call TranscriptFeb 23, 2022A$4.08 (+5.25%)Earnings
- Healius Ltd to Acquire Agilex Biolabs Pty Ltd Call TranscriptDec 17, 2021
- Full Year 2021 Healius Ltd Earnings Call TranscriptAug 30, 2021A$4.32 (-7.34%)Earnings
- Half Year 2021 Healius Ltd Earnings Call TranscriptFeb 24, 2021A$3.69 (+2.31%)Earnings
- Healius Ltd Sustainable Improvements Program and Capital Management Plans Call TranscriptDec 08, 2020
- Healius Ltd Annual Shareholders Meeting TranscriptOct 22, 2020
- Full Year 2020 Healius Ltd Earnings Call TranscriptAug 21, 2020A$3.04 (+0.31%)Earnings
- Healius Ltd Sales of Medical Centres and Market Update Presentation TranscriptJun 15, 2020
- Half Year 2020 Healius Ltd Earnings Call TranscriptFeb 26, 2020A$2.94 (+15.22%)Earnings
- Healius Ltd Annual Shareholders Meeting TranscriptNov 24, 2019
- Full Year 2019 Healius Ltd Earnings Call TranscriptAug 16, 2019A$2.71 (+5.02%)Earnings
Full Year 2020 Healius Ltd Earnings Call Transcript
Good morning, everyone, and thank you for joining us today for the Healius FY '20 results presentation. With me today are Dr. Malcolm Parmenter, our CEO; and Maxine Jacquet, our CFO; and several members of our finance team.
Now as you will have seen, our full year results today include the impacts of AASB 16 on this year's figures, and they also account for Medical Centres as a discontinued operation in both the P&L and balance sheet. And these treatments certainly complicate the underlying results.
So in recognition of everybody's busy schedules, what we're going to try to do today is as follows. Malcolm will give you his take on the results, the current trading and the go forward, and we'll field questions on those matters. We'll then allow people who wanted to drop off the call, and we'll do a second round of Q&A on the technical stuff, if that's okay. So I hope that will make sense, and we'll see how it goes.
So with that, let me pass you over to Malcolm. Thank you.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)